Apidra U/ml, solution for injection in a pre filled pen SoloStar. 2. the pre- filled pen SoloStar, the instructions for use included in the package leaflet must. Apidra SoloStar Units/ml solution for injection in a pre-filled pen . SoloStar, the Instructions for use included in the Package leaflet must be read carefully. Package leaflet: Information for the user. Apidra® SoloStar®. Units/ml solution for injection in a pre-filled pen insulin glulisine. Talk to your doctor.
|Published (Last):||8 October 2016|
|PDF File Size:||15.89 Mb|
|ePub File Size:||10.14 Mb|
|Price:||Free* [*Free Regsitration Required]|
Decreased insulin production may occur in the pancreas due to a direct effect on pancreatic beta cells. Your email has been sent. Moderate Changes in insulin sensitivity or apidra package insert control may occur in patients treated with androgens.
Dosage apidra package insert may be necessary in some patients. Insulin glulisine may be given via intravenous administration under proper insetr supervision in a clinical setting for glycemic control, although dosage, safety, and efficacy information for this route of administration is not available.
Therefore, careful monitoring of blood glucose is recommended when quinolones and antidiabetic agents are coadministered.
Hydrocodone; Potassium Guaiacolsulfonate; Pseudoephedrine: If you are not sure whether you should start apidra package insert this medicine, talk to your doctor. Coconut Oil and Dementia.
The main risk factors for impaired glucose tolerance due to corticosteroids are the dose of steroid and duration of treatment. Monitor blood glucose apidra package insert glycemic control. Moderate The risk of hypoglycemia is increased when lixisenatide is apidra package insert in combination with insulin glulisine. Your doctor may need to adjust your dose of Apidra or of other medicines packsge are taking.
Patients alidra be monitored for worsening of glycemic control if therapy with cyclosporine is initiated in patients receiving insulin. These ratios may change based on individual response.
FDA Internet Application Site (Accessdata) Error
You may need urgent medical attention or hospitalisation. The average duration of glycemic lowering effect in healthy subjects is minutes. Aminosalicylate sodium, Apidra package insert acid: People with type 2 diabetes likely to benefit from 5: Discuss any worries you may have about this with your doctor, pharmacist or diabetes educator. Ethinyl Estradiol; Ethynodiol Diacetate: The apidra package insert or hyperglycemia which occurs during octreotide acetate therapy is usually mild, but may result in overt diabetes mellitus or necessitate dose changes in insulin or other hypoglycemic agents.
Adequate blood glucose monitoring should be continued and followed.
The hyperglycemic effect of diazoxide is expected to be antagonized by certain antidiabetic agents e. Send the page ” ” to a friend, relative, colleague or apidra package insert.
Animal data indicate that MAOIs may stimulate insulin apidra package insert. The dosing of insulin may require adjustment in patients who receive metoclopramide concomitantly.
Insulin requirements may be increased when patients are administered inserr, INH concomitantly. Severe cases, including anaphylactoid reactions, may be life threatening. Patients treated with lanreotide may experience either hypoglycemia or hyperglycemia. Moderate Sodium polystyrene sulfonate should be used cautiously apidra package insert other agents inssert can induce hypokalemia such as loop diuretics, insulins, or intravenous sodium bicarbonate.
Apidra (insulin glulisine) Drug / Medicine Information
Of note, apidra package insert has not been studied apidra package insert combination with insulin. Make sure they know not to give you anything to eat or drink if you are unconscious.
Any change in this medicine should be made cautiously and only under medical supervision. Make sure the tip of the needle is in the Apidra and withdraw the correct dose into the syringe.
Systemic and inhaled corticosteroids are known to increase blood glucose and worsen glycemic control in patients taking antidiabetic agents. In addition, when insulin glulisine is administered IV, patients should be monitored apidra package insert for hypoglycemia. Making sure the tip of the needle is in the insulin, withdraw the prescribed units of NPH insulin.
Keep the apidra package insert in the skin for at least 2 to 4 seconds so that all of the insulin is injected. Because of this, a potential pharmacodynamic interaction exists between these drugs and all antidiabetic agents.